Panel Discussion: Clinically Validating Liquid Biopsies for Early Clinical Endpoints in Solid Tumor to Enhance Patient Selection & Monitoring
3:15 pm - Wednesday 4th February 2026
- What evidence and study designs are most critical to clinically validate liquid biopsies as early endpoints in trials, and how do these differ across indications?
- How can validated liquid biopsy endpoints improve patient selection and ongoing monitoring to accelerate therapeutic development and decision-making?
- Considerations into choosing the right test for the right applications.
